Microglia In Neuroinflammation is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Microglia are the resident immune cells of the central nervous system (CNS), constituting approximately 10-15% of all brain cells. As the primary innate immune effectors in the brain, microglia play critical roles in brain development, homeostasis, immune surveillance, and the inflammatory responses that characterize neurodegenerative diseases.
| Property |
Value |
| Category |
Glial cells |
| Location |
Throughout CNS (brain and spinal cord) |
| Cell Type |
Resident macrophages |
| Origin |
Yolk sac progenitors (embryonic day 7-8) |
| Function |
Immune surveillance, inflammation, synaptic pruning |
¶ Origin and Development
Microglia originate from embryonic yolk sac progenitors that migrate into the developing brain during early embryogenesis (around embryonic day 7-8 in mice). Unlike other immune cells that turn over from bone marrow precursors, microglia are largely self-renewing under normal conditions, maintained through local proliferation.
The development and survival of microglia depend on several key signaling pathways:
- CSF1R signaling: Essential for microglial survival and proliferation
- TREM2 signaling: Critical for disease-associated microglia (DAM) formation
- CX3CR1 signaling: Regulates microglial recruitment and activation
Microglia exhibit remarkable morphological plasticity that correlates with their functional state:
- Small cell body with numerous highly ramified processes
- Processes constantly survey the surrounding neuropil
- Contact synapses every few minutes for monitoring
- Amoeboid morphology with retracted processes
- Enlarged cell body
- Increased expression of activation markers (Iba1, CD68)
- Distinct transcriptional signature
- Associated with neurodegenerative disease progression
- Characterized by upregulation of genes involved in lipid metabolism and phagocytosis
Microglia maintain constant surveillance of the brain environment, monitoring for:
- Pathogen invasion
- Cellular debris
- Abnormal protein aggregates
- Changes in synaptic activity
As professional phagocytes, microglia clear:
- Apoptotic cells during development
- Synaptic debris (synaptic pruning)
- Amyloid-beta plaques in Alzheimer's disease
- Alpha-synuclein aggregates in Parkinson's disease
During development, microglia eliminate excess synapses through complement-mediated phagocytosis, refining neural circuits. This process continues in the adult brain at lower levels, contributing to synaptic plasticity.
¶ Cytokine and Chemokine Production
Activated microglia release pro-inflammatory mediators:
- Cytokines: IL-1β, IL-6, TNF-α, IL-18
- Chemokines: CCL2, CXCL10, CCL5
- Reactive oxygen species (ROS): NADPH oxidase-derived superoxide
- Nitric oxide (NO): Via inducible nitric oxide synthase (iNOS)
Microglia can adopt multiple activation states, broadly categorized as:
- Pro-inflammatory phenotype
- Induced by IFN-γ, LPS, or amyloid-beta
- Produces cytotoxic molecules that can damage neurons
- Associated with chronic neuroinflammation
- Anti-inflammatory, reparative phenotype
- Induced by IL-4, IL-13, or IL-10
- Promotes tissue repair and wound healing
- Characterized by arginase-1 expression and YM1/YM2 markers
- Transcriptional signature distinct from M1/M2
- Upregulated in neurodegenerative diseases
- Characterized by TREM2-dependent activation
- Associated with lipid metabolism and phagocytosis genes
Microglia play complex, dual roles in Alzheimer's disease:
Protective Functions:
- Phagocytic clearance of amyloid-beta plaques
- Production of neurotrophic factors
- Maintenance of blood-brain barrier integrity
Detrimental Effects:
- Chronic activation leading to toxic cytokine release
- Failed clearance of amyloid-beta (due to TREM2 variants)
- Amplification of tau pathology
- Synaptic loss through excessive pruning
Genetic Risk Factors:
- TREM2: Rare variants increase AD risk 3-4x (comparable to APOE4)
- CD33: Variant associated with reduced microglial phagocytosis
- INPP5D: Phosphatase involved in microglial signaling
Microglia contribute to dopaminergic neuron degeneration:
- Chronic neuroinflammation in substantia nigra
- Release of pro-inflammatory cytokines (IL-1β, TNF-α)
- NADPH oxidase-mediated oxidative stress
- Failed clearance of alpha-synuclein aggregates
- Activated microglia in motor cortex and spinal cord
- Release of cytotoxic factors (NO, ROS, cytokines)
- Genetic links: TREM2, UNC13A variants affect microglial function
- Central role in demyelination and lesion formation
- Phagocytic clearance of myelin debris
- Both protective (debris removal) and harmful (myelin attack) roles
- Rapid activation following injury
- Production of inflammatory cytokines
- Secondary neuronal damage
- Potential therapeutic target for neuroprotection
Common microglial markers used in research:
- Iba1 (Ionized calcium-binding adapter molecule 1)
- CD68 (cluster of differentiation 68)
- TMEM119 (Transmembrane protein 119)
- P2RY12 (Purinergic receptor P2Y12)
- CX3CR1 (C-X3-C motif chemokine receptor 1)
- Minocycline: Antibiotic with anti-inflammatory properties (clinical trials in ALS, AD)
- TREM2 agonists: Enhancing microglial phagocytosis
- CSF1R inhibitors: Reducing microglial proliferation
- CX3CR1 antagonists: Reducing harmful microglial activation
- NADPH oxidase inhibitors: Blocking ROS production
- Cytokine blockers: IL-1β or TNF-α inhibitors
The study of Microglia In Neuroinflammation has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Gomez-Nicola & Perry, Microglia in the normal and degenerating brain (2015) - Trends in Neurosciences
- Ransohoff & Perry, Microglial physiology (2009) - Annual Review of Physiology
- Heneka et al., Neuroinflammation in Alzheimer's disease (2015) - Lancet Neurology
- Salter & Stevens, Microglia emerge as central players (2017) - Nature Neuroscience
- Wolf et al., Microglia: biology and functions (2017) - EMBO Journal
- Hansen et al., TREM2 and microglial neurodegeneration (2018) - Trends in Neurosciences
- Sarlus & Heneka, Microglia in Alzheimer's disease (2017) - JCI Insight
- Liddelow et al., Neurotoxic reactive astrocytes (2017) - Nature